Her primary areas of investigation include Parkinson's disease, Neuroscience, Dopaminergic, Internal medicine and Dopamine. Her work in the fields of Dyskinesia and Pars compacta overlaps with other areas such as Placebo-controlled study. Her study of Basal ganglia is a part of Neuroscience.
Her Internal medicine study combines topics from a wide range of disciplines, such as Endocrinology and In vivo. Her research integrates issues of Huntington's disease, Asymptomatic, Subclinical infection and Degenerative disease in her study of Endocrinology. Paola Piccini works mostly in the field of Putamen, limiting it down to concerns involving Central nervous system disease and, occasionally, Pathology.
Paola Piccini mainly investigates Parkinson's disease, Neuroscience, Internal medicine, Dopaminergic and Putamen. Her Parkinson's disease study integrates concerns from other disciplines, such as Caudate nucleus and Dopamine transporter. Her work on Striatum, Basal ganglia and Positron emission tomography as part of her general Neuroscience study is frequently connected to Clinical neurology, thereby bridging the divide between different branches of science.
Her research investigates the connection with Internal medicine and areas like Endocrinology which intersect with concerns in Serotonergic, Degenerative disease and Serotonin. Her Dopaminergic study is concerned with Dopamine in general. While the research belongs to areas of Putamen, Paola Piccini spends her time largely on the problem of Asymptomatic, intersecting her research to questions surrounding Subclinical infection.
Her primary areas of study are Parkinson's disease, Internal medicine, Neuroscience, Putamen and Dopaminergic. Pathology covers Paola Piccini research in Parkinson's disease. Her Internal medicine research is multidisciplinary, incorporating elements of Longitudinal study, Endocrinology and Oncology.
Her studies in Neuroscience integrate themes in fields like Molecular imaging and Neuroinflammation, Disease. Paola Piccini has researched Putamen in several fields, including Gastroenterology, Caudate nucleus, Levodopa, Globus pallidus and Voxel. Within one scientific family, Paola Piccini focuses on topics pertaining to Striatum under Dopamine transporter, and may sometimes address concerns connected to Mri scan.
Paola Piccini spends much of her time researching Parkinson's disease, Neuroscience, Internal medicine, Putamen and Dopaminergic. Parkinson's disease is a subfield of Pathology that Paola Piccini explores. Her Neuroscience study combines topics in areas such as Molecular imaging and Atypical Parkinsonism.
Her Putamen research integrates issues from Caudate nucleus and Surgery. As part of her research on Dopaminergic, studies on Endocrinology and Dopamine are part of the effort. Her studies deal with areas such as Levodopa and Serotonergic as well as Endocrinology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient
Paola Piccini;David J. Brooks;Anders Björklund;Roger N. Gunn.
Nature Neuroscience (1999)
Increased dopamine tone during meditation-induced change of consciousness
Troels W Kjaer;Camilla Bertelsen;Paola Piccini;David Brooks.
Cognitive Brain Research (2002)
Dyskinesias following neural transplantation in Parkinson's disease
Peter Hagell;Paola Piccini;Anders Björklund;Patrik Brundin.
Nature Neuroscience (2002)
Compulsive drug use linked to sensitized ventral striatal dopamine transmission.
Andrew H. Evans;Nicola Pavese;Andrew David Lawrence;Yen F. Tai.
Annals of Neurology (2006)
Priorities in Parkinson's disease research
Wassilios G Meissner;Wassilios G Meissner;Mark Frasier;Thomas Gasser;Christopher G Goetz.
Nature Reviews Drug Discovery (2011)
The role of inheritance in sporadic Parkinson's disease: evidence from a longitudinal study of dopaminergic function in twins.
Paola Piccini;David J. Burn;Roberto Ceravolo;Demetrius Maraganore.
Annals of Neurology (1999)
Parkinson's Disease Symptoms: The Patient's Perspective
Marios Politis;Kit Wu;Sophie Molloy;Peter G. Bain.
Movement Disorders (2010)
Microglial activation in presymptomatic Huntington's disease gene carriers
Yen F. Tai;Nicola Pavese;Alexander Gerhard;Sarah J. Tabrizi.
Brain (2007)
Delayed recovery of movement-related cortical function in Parkinson's disease after striatal dopaminergic grafts
Paola Piccini;Olle Lindvall;Anders Björklund;Patrik Brundin.
Annals of Neurology (2000)
Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson's disease: clinical, pathological, olfactory and functional imaging and genetic data.
Naheed L. Khan;Shushant Jain;John M. Lynch;Nicola Pavese.
Brain (2005)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
King's College London
Newcastle University
Aarhus University Hospital
University College London
University of Cambridge
University College London
Lund University
Imperial College London
University College London
University College London
Nagoya University
Chinese Academy of Sciences
North Carolina State University
Victor Chang Cardiac Research Institute
Max Planck Society
University of Arkansas at Fayetteville
Yale University
Heinrich Heine University Düsseldorf
Hospital for Special Surgery
University of Duisburg-Essen
Birkbeck, University of London
University of California, Irvine
University of Maryland, College Park
University of California, Berkeley
University of Toronto
Institut d'Astrophysique de Paris